Hi Friends,
The recent approval of ibrutinib for 17p deletion frontline hopefully is the opening wedge of more indications for treatment naive patients for it and other non-chemo choices.
I have posted why this is so important and a list with links to some important clinical trials on my latest blog post bkoffman.blogspot.com
Thanks. Stay strong
Brian